Logo image of NAMI

JINXIN TECHNOLOGY HOLDIN-ADR (NAMI) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:NAMI - US47760D1028 - ADR

0.789 USD
-0.02 (-2.57%)
Last: 12/24/2025, 7:49:53 PM
0.7996 USD
+0.01 (+1.34%)
After Hours: 12/24/2025, 7:49:53 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to NAMI. NAMI was compared to 77 industry peers in the Diversified Consumer Services industry. While NAMI has a great health rating, there are worries on its profitability. NAMI does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

NAMI had positive earnings in the past year.
NAMI Yearly Net Income VS EBIT VS OCF VS FCFNAMI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

The Return On Assets of NAMI (8.20%) is better than 76.62% of its industry peers.
The Return On Equity of NAMI (16.67%) is better than 76.62% of its industry peers.
Looking at the Return On Invested Capital, with a value of 13.76%, NAMI belongs to the top of the industry, outperforming 90.91% of the companies in the same industry.
Industry RankSector Rank
ROA 8.2%
ROE 16.67%
ROIC 13.76%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NAMI Yearly ROA, ROE, ROICNAMI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 20 40 60

1.3 Margins

The Profit Margin of NAMI (4.93%) is better than 61.04% of its industry peers.
NAMI has a Operating Margin (6.65%) which is in line with its industry peers.
NAMI has a worse Gross Margin (28.82%) than 64.94% of its industry peers.
Industry RankSector Rank
OM 6.65%
PM (TTM) 4.93%
GM 28.82%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NAMI Yearly Profit, Operating, Gross MarginsNAMI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 10 20 30 40

More info and screens

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), NAMI is creating value.
Compared to 1 year ago, NAMI has less shares outstanding
NAMI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
NAMI Yearly Shares OutstandingNAMI Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 20M 40M 60M
NAMI Yearly Total Debt VS Total AssetsNAMI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 3.23 indicates that NAMI is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.23, NAMI is in the better half of the industry, outperforming 77.92% of the companies in the same industry.
There is no outstanding debt for NAMI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.23
ROIC/WACC1.83
WACC7.54%
NAMI Yearly LT Debt VS Equity VS FCFNAMI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 0 50M 100M

2.3 Liquidity

A Current Ratio of 1.66 indicates that NAMI should not have too much problems paying its short term obligations.
NAMI has a better Current ratio (1.66) than 70.13% of its industry peers.
NAMI has a Quick Ratio of 1.62. This is a normal value and indicates that NAMI is financially healthy and should not expect problems in meeting its short term obligations.
NAMI has a Quick ratio of 1.62. This is in the better half of the industry: NAMI outperforms 68.83% of its industry peers.
Industry RankSector Rank
Current Ratio 1.66
Quick Ratio 1.62
NAMI Yearly Current Assets VS Current LiabilitesNAMI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 50M 100M 150M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for NAMI have decreased strongly by -33.33% in the last year.
NAMI shows a small growth in Revenue. In the last year, the Revenue has grown by 6.84%.
EPS 1Y (TTM)-33.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)6.84%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NAMI Yearly Revenue VS EstimatesNAMI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 100M 200M 300M 400M

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 7.89, which indicates a rather cheap valuation of NAMI.
NAMI's Price/Earnings ratio is rather cheap when compared to the industry. NAMI is cheaper than 89.61% of the companies in the same industry.
NAMI is valuated cheaply when we compare the Price/Earnings ratio to 26.59, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 7.89
Fwd PE N/A
NAMI Price Earnings VS Forward Price EarningsNAMI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, NAMI is valued a bit cheaper than the industry average as 79.22% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.64
NAMI Per share dataNAMI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6 0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

NAMI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

JINXIN TECHNOLOGY HOLDIN-ADR

NASDAQ:NAMI (12/24/2025, 7:49:53 PM)

After market: 0.7996 +0.01 (+1.34%)

0.789

-0.02 (-2.57%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)12-22 2025-12-22
Earnings (Next)04-13 2026-04-13
Inst Owners0.16%
Inst Owner Change15.67%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap53.94M
Revenue(TTM)406.00M
Net Income(TTM)20.00M
AnalystsN/A
Price TargetN/A
Short Float %0.04%
Short Ratio0.44
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 7.89
Fwd PE N/A
P/S 0.93
P/FCF N/A
P/OCF N/A
P/B 3.18
P/tB 7.28
EV/EBITDA 6.64
EPS(TTM)0.1
EY12.67%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.85
BVpS0.25
TBVpS0.11
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0.75
Profitability
Industry RankSector Rank
ROA 8.2%
ROE 16.67%
ROCE 17.42%
ROIC 13.76%
ROICexc 13.76%
ROICexgc 24.24%
OM 6.65%
PM (TTM) 4.93%
GM 28.82%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.66
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.66
Quick Ratio 1.62
Altman-Z 3.23
F-ScoreN/A
WACC7.54%
ROIC/WACC1.83
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-33.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.84%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-66.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-179.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-54.39%
OCF growth 3YN/A
OCF growth 5YN/A

JINXIN TECHNOLOGY HOLDIN-ADR / NAMI FAQ

What is the fundamental rating for NAMI stock?

ChartMill assigns a fundamental rating of 4 / 10 to NAMI.


Can you provide the valuation status for JINXIN TECHNOLOGY HOLDIN-ADR?

ChartMill assigns a valuation rating of 3 / 10 to JINXIN TECHNOLOGY HOLDIN-ADR (NAMI). This can be considered as Overvalued.


What is the profitability of NAMI stock?

JINXIN TECHNOLOGY HOLDIN-ADR (NAMI) has a profitability rating of 3 / 10.


How financially healthy is JINXIN TECHNOLOGY HOLDIN-ADR?

The financial health rating of JINXIN TECHNOLOGY HOLDIN-ADR (NAMI) is 8 / 10.